Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management

NCT06022614 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Erector Spinae Plane Block

Interventions

DRUG: Use Bupivacaine 0.25% Injectable Solution
DRUG: Bupivacaine 0.25% Injectable Solution plus Dexmedetomidine

Sponsor

Abanoub Habib